Aadi Bioscience Inc (NAS:AADI)
$ 1.99 0.03 (1.53%) Market Cap: 48.98 Mil Enterprise Value: -29.27 Mil PE Ratio: 0 PB Ratio: 0.62 GF Score: 42/100

Q2 2023 Aadi Bioscience Inc Earnings Call Transcript

Aug 09, 2023 / 12:30PM GMT
Release Date Price: $5.44 (-6.85%)
Operator

Good day, and thank you for standing by. Welcome to the Aadi Bioscience, Inc. Second Quarter 2023 Earnings Call. (Operator Instructions) Please be advised that today's conference is being recorded.

I would now like to hand the conference over to Marcy Graham, Senior Vice President of Investor Relations and Corporate Communications at Aadi Biosciences. Ms. Graham?

Marcy Graham
Aadi Bioscience, Inc. - SVP of IR & Corporate Communications

Thank you. Good morning, and welcome to the Aadi Bioscience conference call to provide an operational update and review results of the second quarter 2023.

Joining me on the call today is Scott Giacobello, our CFO and Interim President and CEO, who will provide an overview of financial and operational activity during the period, including an update on our continued commercial progress. And he will be followed by our Chief Medical Officer, Dr. Loretta Itri, who will provide an update on our PRECISION 1 study and clinical development plans for 2023. We will open the line for questions at the end of the call

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot